Aliya Khan is a Clinical Professor of Medicine in the Division of Endocrinology and Geriatrics at McMaster University, Director of the Calcium Disorders Clinic, and Director of the Fellowship in Metabolic Bone Disease at McMaster University. She graduated from the University of Ottawa Medical School with honors. She trained in Internal Medicine, Geriatric Medicine and Endocrinology and also completed a fellowship in Metabolic Bone Disease at the University of Toronto. She has published over 200 scientific papers and numerous chapters and books on osteoporosis and parathyroid disease.

Dr. Khan led the development of global guidelines for parathyroid disease, osteonecrosis of the jaw, new diagnostic criteria for hypophosphatasia , as well as treatment guidelines for X-linked hypophosphatemia in addition to Canadian guidelines for osteoporosis.

She is the principle investigator evaluating novel therapies for parathyroid disease including PTH and PTH analogues as well PTH1receptor agonists for the treatment of hypoparathyroidism including palopegteriparatide, natpar, eneboparatide as well as the calcilytic molecule encalaret for the treatment of autosomal dominant hypocalcemia. In addition she was the principle investigator evaluating bisphosphonate therapy as well as the calcimetic cinacalcet for the medical management of primary hyperparathyroidism.

She has received numerous national and international awards including the Queen’s Diamond Jubilee Medal for excellence, International Hypoparathyroidism Award, International Osteoporosis Foundation award for publishing excellence and recognized by Osteoporosis Canada for outstanding contributions to research and education. In 2024 she was the recipient of the Woman Physician of the Year Award by the American College of Physicians (ACP) Ontario Chapter honoring an outstanding woman physician with a distinguished career in areas of exceptional patient care, medical education and/or research. She also received the ACP Humanitarian of the Year Award given for outstanding contributions to humanism in medicine and also recognizes scholarly activities in literature, philosophy, and ethics. She is recognized as being in the top 0.1% of the world experts in hyperparathyroidism by Expertscape

Aliya Khan is a Clinical Professor of Medicine in the Division of Endocrinology and Geriatrics at McMaster University, Director of the Calcium Disorders Clinic, and Director of the Fellowship in Metabolic Bone Disease at McMaster University. She graduated from the University of Ottawa Medical School with honors. She trained in Internal Medicine, Geriatric Medicine and Endocrinology and also completed a fellowship in Metabolic Bone Disease at the University of Toronto. She has published over 200 scientific papers and numerous chapters and books on osteoporosis and parathyroid disease.

Dr. Khan led the development of global guidelines for parathyroid disease, osteonecrosis of the jaw, new diagnostic criteria for hypophosphatasia , as well as treatment guidelines for X-linked hypophosphatemia in addition to Canadian guidelines for osteoporosis.

She is the principle investigator evaluating novel therapies for parathyroid disease including PTH and PTH analogues as well PTH1receptor agonists for the treatment of hypoparathyroidism including palopegteriparatide, natpar, eneboparatide as well as the calcilytic molecule encalaret for the treatment of autosomal dominant hypocalcemia. In addition she was the principle investigator evaluating bisphosphonate therapy as well as the calcimetic cinacalcet for the medical management of primary hyperparathyroidism.

She has received numerous national and international awards including the Queen’s Diamond Jubilee Medal for excellence, International Hypoparathyroidism Award, International Osteoporosis Foundation award for publishing excellence and recognized by Osteoporosis Canada for outstanding contributions to research and education. In 2024 she was the recipient of the Woman Physician of the Year Award by the American College of Physicians (ACP) Ontario Chapter honoring an outstanding woman physician with a distinguished career in areas of exceptional patient care, medical education and/or research. She also received the ACP Humanitarian of the Year Award given for outstanding contributions to humanism in medicine and also recognizes scholarly activities in literature, philosophy, and ethics. She is recognized as being in the top 0.1% of the world experts in hyperparathyroidism by Expertscape

Dr. Alexandra Papaioannou is a professor in the Department of Medicine and a geriatrician at Hamilton Health Sciences.  She is Executive Director of the Geriatric Education and Research in Aging Sciences (GERAS) Centre at Hamilton Health Sciences.  She holds an Eli Lilly Research Chair at McMaster University.  She has a joint appointment in the Division of Rheumatology, and is past Director, Division of Geriatric Medicine, McMaster.  Dr Papaioannou is an Associate Member in the Department of Health Research Methods, Evidence and Impact, and a faculty member in the Medical Sciences, Physiology & Pharmacology Graduate Studies Program.  She is a member of the Gilbrea Centre Advisory Board, and McMaster Institute for Research on Aging (MIRA).  She is past chair of the Scientific Advisory Council of Osteoporosis Canada (OC) and past Chair of the Board.  She is a member of the Scientific Advisors of Osteoporosis Canada, and the International Osteoporosis Foundation.  Dr. Papaioannou was lead author on the Osteoporosis Canada Guidelines published in Canadian Medical Association Journal (CMAJ) October 2010 and 2015.  Dr. Papaioannou was awarded an Ontario Career Scientist Award.  She is author of more than 300 peer reviewed publications with a focus on frailty, falls and fractures. She is the project lead for the Ontario Osteoporosis Strategy for Fracture Prevention in Long-term Care, and Co-Director of the Hamilton Canadian Multi-Centre Osteoporosis Study (CaMos).

Dr. Papaioannou has received a number of awards including the Ronald Cape Distinguished Service Award, to recognize an individual who has made an outstanding contribution to the health care of older adults in Canada, the Service Award for Geriatric Excellence (SAGE), Category: Executive/Senior Leadership, awarded by the Regional Geriatric Program central (RGPc), the  McMaster Department of Medicine Teaching Award for Postgraduate Teaching, the Ontario College of Family Physicians Certificate of Recognition for her contributions to primary care, the YWCA Hamilton Women of Distinction Award – Health & Wellness, and the Lindy Fraser Award from Osteoporosis Canada.

Dr. Alexandra Papaioannou is a professor in the Department of Medicine and a geriatrician at Hamilton Health Sciences.  She is Executive Director of the Geriatric Education and Research in Aging Sciences (GERAS) Centre at Hamilton Health Sciences.  She holds an Eli Lilly Research Chair at McMaster University.  She has a joint appointment in the Division of Rheumatology, and is past Director, Division of Geriatric Medicine, McMaster.  Dr Papaioannou is an Associate Member in the Department of Health Research Methods, Evidence and Impact, and a faculty member in the Medical Sciences, Physiology & Pharmacology Graduate Studies Program.  She is a member of the Gilbrea Centre Advisory Board, and McMaster Institute for Research on Aging (MIRA).  She is past chair of the Scientific Advisory Council of Osteoporosis Canada (OC) and past Chair of the Board.  She is a member of the Scientific Advisors of Osteoporosis Canada, and the International Osteoporosis Foundation.  Dr. Papaioannou was lead author on the Osteoporosis Canada Guidelines published in Canadian Medical Association Journal (CMAJ) October 2010 and 2015.  Dr. Papaioannou was awarded an Ontario Career Scientist Award.  She is author of more than 300 peer reviewed publications with a focus on frailty, falls and fractures. She is the project lead for the Ontario Osteoporosis Strategy for Fracture Prevention in Long-term Care, and Co-Director of the Hamilton Canadian Multi-Centre Osteoporosis Study (CaMos).

Dr. Papaioannou has received a number of awards including the Ronald Cape Distinguished Service Award, to recognize an individual who has made an outstanding contribution to the health care of older adults in Canada, the Service Award for Geriatric Excellence (SAGE), Category: Executive/Senior Leadership, awarded by the Regional Geriatric Program central (RGPc), the  McMaster Department of Medicine Teaching Award for Postgraduate Teaching, the Ontario College of Family Physicians Certificate of Recognition for her contributions to primary care, the YWCA Hamilton Women of Distinction Award – Health & Wellness, and the Lindy Fraser Award from Osteoporosis Canada.